Uterine fibroid treatment could reduce need for surgery

A NEW development in the treatment of uterine fibroids that could enable thousands of women to avoid hysterectomies and other major surgery has been authorised by the European Commission (EC).


Ulipristal acetate – or Esmya – is an oral treatment for the moderate to severe symptoms of uterine fibroids in adult women of reproductive age, that gives rapid control of uterine bleeding, reduces anaemia and shrinks the size of fibroids.

Read more HERE.

Leave a Comment